Search results for "confidence interval"

showing 10 items of 1297 documents

Impact of Circulatory Assistance in the Early Evolution After Heart Transplantation. Unicentric Experience.

2021

ABSTRACT Background Heart transplantation (HT) is the reference treatment for patients with terminal heart failure. In recent years there has been a progressive increase in HT procedures in patients who have a circulatory support (CS). Methods This is a retrospective single-center study of 293 consecutive patients who underwent HT from 2009 to 2018, analyzing the evolution of the 2 cohorts: patients with and without CS as a bridge to HT. Baseline and evolutionary clinical data collected following the usual follow-up protocol were recorded, including clinical events observed during the follow-up 1 year after the procedure. Results The subgroup of patients transplanted with CS showed a higher…

Heart transplantationMechanical ventilationHeart FailureTransplantationmedicine.medical_specialtyMultivariate analysisbusiness.industryIncidence (epidemiology)medicine.medical_treatmentOdds ratiomedicine.diseasePrognosisConfidence intervalHeart failureInternal medicineCirculatory systemmedicineCardiologyHeart TransplantationHumansSurgerybusinessFollow-Up StudiesRetrospective StudiesTransplantation proceedings
researchProduct

Quality-related variables at hepatological websites

2004

Abstract Background. The amount of hepatology-related information available on the Internet has substantially increased, but little is known about the characteristics and quality of the websites. Aim. The aim of this study was to describe analytically and evaluate critically the information concerning three diseases of hepatological interest: chronic hepatitis, hemochromatosis and Caroli’s disease. Methods. In accordance with a validated method, the three search terms were entered into four English language search engines and the first five links of each were considered (a total of 60 sites). The characteristics of the websites were described and their quality was evaluated by three indepen…

HemochromatosiWritingmedia_common.quotation_subjectDiseaseCertificationLogistic regressionChronic hepatitisHumansMedicineQuality (business)media_commonInternetHepatologyConflict of Interestbusiness.industryCaroli's diseaseLiver DiseasesGastroenterologyOdds ratioAuthorshipCaroli DiseaseConfidence intervalLogistic ModelsSearch termsChronic DiseaseChronic hepatitiHemochromatosisbusinessDemographyDigestive and Liver Disease
researchProduct

PEG IFN alfa-2a vs. alfa-2b: And the winner is …?

2009

Abstract Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. McHutchison JG, Lawitz EJ, Shiffman ML, Muir AJ, Galler GW, McCone J, Nyberg LM, Lee WM, Ghalib RH, Schiff ER, Galati JS, Bacon BR, Davis MN, Mukhopadhyay P, Koury K, Noviello S, Pedicone LD, Brass CA, Albrecht JK, Sulkowski MS; IDEAL Study Team. N Engl J Med 2009 Aug 6;361(6):580–93. Background Treatment guidelines recommend the use of peginterferon alfa-2b or peginterferon alfa-2a in combination with ribavirin for chronic hepatitis C virus (HCV) infection. However, these regimens have not been adequately compared. Methods At 118 sites, patients who had HCV genotype 1 infection and who had not …

Hepatitismedicine.medical_specialtyHepatologybusiness.industryRibavirinvirus diseasesHepatitis Cmedicine.diseaseGastroenterologyChronic hepatitis HCV Head-to-head studies Pegylated interferons Ribavirindigestive system diseasesConfidence intervalSurgeryRegimenchemistry.chemical_compoundPharmacotherapystomatognathic systemchemistryTolerabilityInternal medicineMedicinebusinessAdverse effectJournal of Hepatology
researchProduct

Testing for goodness rather than lack of fit of an X–chromosomal SNP to the Hardy-Weinberg model

2019

The problem of checking the genotype distribution obtained for some diallelic marker for compatibility with the Hardy-Weinberg equilibrium (HWE) condition arises also for loci on the X chromosome. The possible genotypes depend on the sex of the individual in this case: for females, the genotype distribution is trinomial, as in the case of an autosomal locus, whereas a binomial proportion is observed for males. Like in genetic association studies with autosomal SNPs, interest is typically in establishing approximate compatibility of the observed genotype frequencies with HWE. This requires to replace traditional methods tailored for detecting lack of fit to the model with an equivalence test…

HeredityNormal DistributionDistance MeasurementTrinomial01 natural sciencesLinkage Disequilibrium010104 statistics & probabilityStatisticsLack-of-fit sum of squaresMathematicsVenous ThrombosisMeasurement0303 health sciencesMultidisciplinaryQRSoftware EngineeringGenomicsHardy–Weinberg principleGenetic MappingPhysical SciencesEngineering and TechnologyMedicineResearch ArticleComputer and Information SciencesScienceGeometryAsymptotic distributionVariant GenotypesPolymorphism Single NucleotideMolecular Genetics03 medical and health sciencesGenome-Wide Association StudiesGeneticsTest statisticHumansComputer Simulation0101 mathematicsMolecular BiologyGenetic Association Studies030304 developmental biologyChromosomes Human XModels StatisticalModels GeneticSoftware ToolsBiology and Life SciencesComputational BiologyHuman GeneticsGenome AnalysisProbability TheoryProbability DistributionGenotype frequencyRadiiSample size determinationSample SizeBinomial proportion confidence intervalMathematicsPLOS ONE
researchProduct

Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer

2018

The aim of this multicenter study was to investigate the prognostic role of neutrophil-to-lymphocyte ratio (NLR) and to validate the NLR cutoff of 3 in a large multi-institutional cohort of patients with primary T1 HG/G3 non-muscle-invasive bladder cancer (NMIBC).

High risk; High-grade; NLR; Progression; RecurrenceMaleNeutrophilsmedicine.medical_treatment030232 urology & nephrologySettore MED/24 - Urologia0302 clinical medicineRecurrenceHigh-gradeRecurrence.LymphocytesHigh risk; High-grade; NLR; Progression; Recurrence; Oncology; UrologyAged 80 and overProgressionHigh riskMiddle AgedPrognosis3. Good healthAdministration IntravesicalOncologyChemotherapy Adjuvant030220 oncology & carcinogenesisCohortBCG VaccineDisease ProgressionFemaleNon muscle invasiveAdjuvantAdultmedicine.medical_specialtyUrologyUrologyCystectomyDisease-Free SurvivalNLRResection03 medical and health sciencesmedicineHumansLymphocyte CountNeutrophil to lymphocyte ratioAgedRetrospective StudiesScience & TechnologyBladder cancerbusiness.industryfungimedicine.diseaseConfidence intervalUrinary Bladder NeoplasmsMulticenter studyNeoplasm Recurrence LocalbusinessClinical Genitourinary Cancer
researchProduct

Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19

2020

Purpose To assess efficacy and safety of chloroquine (CQ)/hydroxychloroquine (HCQ) for treatment or prophylaxis of COVID-19 in adult humans. Materials and methods MEDLINE, PubMed, EMBASE and two pre-print repositories (bioRxiv, medRxiv) were searched from inception to 8th June 2020 for RCTs and nonrandomized studies (retrospective and prospective, including single-arm, studies) addressing the use of CQ/HCQ in any dose or combination for COVID-19. Results Thirty-two studies were included (6 RCTs, 26 nonrandomized, 29,192 participants). Two RCTs had high risk, two ‘some concerns’ and two low risk of bias (Rob2). Among nonrandomized studies with comparators, nine had high risk and five moderat…

ICU Intensive care unit;medicine.medical_treatmentCritical Care and Intensive Care MedicineRR Risk Ratio0302 clinical medicineChloroquineRCT Randomized clinical trialMedicineHCQ Hydroxychloroquine;Prospective StudiesProspective cohort studyChloroquine COVID-19 Hydroxychloroquine Mortality SARS-CoV-2ChloroquineECG Electrocardiogram;Rob2 Revised tool for Risk of Bias in randomized trials;CI Confidence interval;Coronavirus InfectionsPost-Exposure ProphylaxisHydroxychloroquinemedicine.drugmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Pneumonia ViralMEDLINEContext (language use)Antiviral AgentsArticleWHO World Health OrganizationBetacoronavirus03 medical and health sciencesInternal medicineHumansMortalityCOVID-19 Coronavirus disease 2019;Post-exposure prophylaxisPandemicsRetrospective StudiesCQ Chloroquine;SARS-CoV-2ROBINS-I Risk of Bias in Non-randomized Studies of Interventions;business.industryCOVID-19030208 emergency & critical care medicineHydroxychloroquineRetrospective cohort studyHCWs Healthcare workers;NOS Newcastle Ottawa Scale;COVID-19 Drug Treatment030228 respiratory systembusinessHR Hazard Ratio;Journal of Critical Care
researchProduct

Inter-observer variability of central corneal thickness measurements using non-contact specular microscopy after laser in situ keratomileusis.

2003

BACKGROUND The aim of this study was to investigate the inter-observer variability of central corneal thickness measurements carried out with a non-contact specular microscope in patients who had undergone myopic laser in situ keratomileusis. METHODS Twenty-six eyes of 26 subjects who had undergone myopic laser in situ keratomileusis were studied with the Topcon SP-2000P non-contact specular microscope (Topcon Corp, Tokyo, Japan). The mean of three consecutive measurements of the central corneal thickness was recorded by two investigators prior to and one month after myopic laser in situ keratomileusis. Results obtained by each of the two physicians were compared. RESULTS Prior to surgery t…

In situAdultMalemedicine.medical_specialtygenetic structuresmedicine.medical_treatmentKeratomileusis Laser In SituKeratomileusislaw.inventionCornealawOphthalmologymedicineMyopiaHumansBody Weights and MeasuresPostoperative PeriodObserver VariationMicroscopyExcimer laserbusiness.industryLASIKLasereye diseasesConfidence intervalOphthalmologySPECULAR MICROSCOPYOptometryFemalesense organsbusinessObserver variationOptometryClinicalexperimental optometry
researchProduct

Management of returned anti-neoplastic treatments and their reuse in oncology patients

2009

Abstract Objective Analyse the profile of parenteral preparation and treatment (anti-neoplastic and supplementary) that were dispensed and returned to the Pharmacy Department, the reasons why they were not administered, their reuse and the associated direct costs. Method Longitudinal study over 8 months (October 2004-May 2005) in a tertiary hospital with centre for preparing anti-neoplastic agents (including supplementary treatment) in its Pharmacy Department. The variables studied, downloaded from the Oncofarm® application, are as follows: a) patients and diagnostics; b) returned treatments, classified by reason returned, pharmaco-therapeutic scheme, cycle, and day; c) returned preparation…

Indirect costsmedicine.medical_specialtybusiness.industryInternal medicineSafety criteriaMedicineOncology patientsPharmacybusinessAnti neoplasticLevofolinic acidConfidence intervalFarmacia Hospitalaria (English Edition)
researchProduct

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021

2021

COVID study groups - PORTUGAL: Portuguese Laboratory Network for the Diagnosis of COVID-19 and Public Health Department of the Health Administrative Regions, Physicians that provided data and samples from suspected cases and SARS-CoV-2 genetic characterization. INSA laboratory team for the diagnosis of SARS-CoV-2. Algarve Biomedical Center and Unilabs. We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0-2.9; B.1.351: 3.6, 95…

Infecções Respiratórias2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Critical CareEpidemiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)variants of concernSettore MED/42 - Igiene Generale E Applicata03 medical and health sciences0302 clinical medicineVirologyInternal medicineMedicineHumansIntensive care admission030212 general & internal medicineCOVID-19; Europe; SARS-CoV-2; surveillance; variants of concern; Critical Care; Europe; Humans; COVID-19; SARS-CoV-2Surveillancebusiness.industrySARS-CoV-2030503 health policy & servicesPublic Health Environmental and Occupational HealthCOVID-19Odds ratioConfidence intervalEuropesurveillanceVariants of ConcernCOVID-19 Europe SARS-CoV-2 surveillance variants of concern0305 other medical sciencebusinessRapid CommunicationHuman
researchProduct

Modelling and forecasting mortality in Spain

2008

[EN] Experience shows that static life tables overestimate death probabilities. As a consequence of this overestimation the premiums for annuities, pensions and life insurance are not what they actually should be, with negative effects for insurance companies or policy-holders. The reason for this overestimation is that static life tables, through being computed for a specific period of time, cannot take into account the decreasing mortality trend over time. Dynamic life tables overcome this problem by incorporating the influence of the calendar when graduating mortality. Recent papers on the topic look for the development of new methods to deal with this dynamism. Most methods used in dyna…

Information Systems and ManagementLee–CarterGeneral Computer ScienceESTADISTICA E INVESTIGACION OPERATIVAManagement Science and Operations ResearchLee carterIndustrial and Manufacturing EngineeringDynamic life tablesMortality dataModeling and SimulationLife insuranceEconomicsEconometricsStatistical analysisDynamismBootstrap confidence intervalParametric statisticsForecastingBootstrap confidence intervals
researchProduct